<--- Back to Details
First PageDocument Content
Pharmaceutical sciences / Food and Drug Administration / Adverse effect / Good manufacturing practice / Pharmacovigilance / Health Products and Food Branch / Norfloxacin / Food and Drugs Act / Drug Identification Number / Pharmacology / Health / Medicine
Date: 2013-07-09 17:13:15
Pharmaceutical sciences
Food and Drug Administration
Adverse effect
Good manufacturing practice
Pharmacovigilance
Health Products and Food Branch
Norfloxacin
Food and Drugs Act
Drug Identification Number
Pharmacology
Health
Medicine

Untitled Document This content was archived on June 24, 2013. Archived Content Information identified as archived on the Web is for reference, research or recordkeeping purposes. It

Add to Reading List

Source URL: hc-sc.gc.ca

Download Document from Source Website

File Size: 126,80 KB

Share Document on Facebook

Similar Documents

Design for Test (DfT) Consultancy  DfT Consulting Services Good practice in DfT during SoC design and verification can improve time to market and reduce manufacturing costs.

Design for Test (DfT) Consultancy DfT Consulting Services Good practice in DfT during SoC design and verification can improve time to market and reduce manufacturing costs.

DocID: 1tBJF - View Document

Use of wooden shelves for cheese aging Microbial pathogens can be controlled if food facilities engage in good manufacturing practice. Proper cleaning and sanitation of equipment and facilities are absolutely necessary t

Use of wooden shelves for cheese aging Microbial pathogens can be controlled if food facilities engage in good manufacturing practice. Proper cleaning and sanitation of equipment and facilities are absolutely necessary t

DocID: 1tjBZ - View Document

15 FebruaryMinistry of Health PO Box 5013 Wellington 6145 By email:

15 FebruaryMinistry of Health PO Box 5013 Wellington 6145 By email:

DocID: 1rt2X - View Document

supported by the  EuBIS European Blood Inspection System Initiated under the Public Health Programme of the European Commission, DG Sanco, EC – GA No

supported by the EuBIS European Blood Inspection System Initiated under the Public Health Programme of the European Commission, DG Sanco, EC – GA No

DocID: 1rj7D - View Document

Microsoft Word - MRI_Rebuttal_NYTimes_Article_1-7-14_Final.docx

Microsoft Word - MRI_Rebuttal_NYTimes_Article_1-7-14_Final.docx

DocID: 1r1ru - View Document